Tenapanor for the treatment of irritable bowel syndrome with constipation-Reference-Cited by-同舟云学术

Tenapanor for the treatment of irritable bowel syndrome with constipation

Published:2020-05-03 Issue:5 Volume:13 Page:473-479
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Sinagra Emanuele¹²,Rossi Francesca¹,Raimondo Dario¹,Conoscenti Giuseppe¹,Anderloni Andrea³,Guarnotta Valentina⁴,Maida Marcello⁵

Affiliation:

1. Gastroenterology and Endoscopy Unit, Fondazione Istituto G. Giglio, Contrada Pietra Pollastra Pisciotto, Cefalù, Italy

2. Section of Nutrition, Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy

3. Digestive Endoscopy Unit, Division of Gastroenterology, Humanitas Research Hospital, Rozzano Italy

4. Dipartimento Di Promozione Della Salute, Materno-Infantile, Medicina Interna E Specialistica Di Eccellenza “G. D’Alessandro” (PROMISE), Sezione Di Malattie Endocrine, Del Ricambio E Della Nutrizione, Università Di Palermo, Italy

5. Section of Gastroenterology, S.Elia - Raimondi Hospital, Caltanissetta, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2020.1762570

Reference47 articles.

1. Psychopharmacological Treatment and Psychological Interventions in Irritable Bowel Syndrome

2. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies;Nefrología;2024-06

2. Focal Active Colitis: What Are Its Clinical Implications? A Narrative Review;Biomedicines;2023-09-25

3. Trust Your Gut: Strategies and Tactics for Intestinally Restricted Drugs;ACS Medicinal Chemistry Letters;2023-02-22

4. Potential Targets in Constipation Research: A Review;Current Drug Targets;2023-02

5. The NHE3 Inhibitor Tenapanor Prevents Intestinal Obstructions in CFTR-Deleted Mice;International Journal of Molecular Sciences;2022-09-01